Corporate Goveranance
Our Governance Documentation
The Company’s Corporate Governance Plan and its Corporate Governance Statement are available for download using the below links.
The Corporate Governance Statement details the extent to which the Company follows the recommendations set by the ASX Corporate Governance Council in its publication “Corporate Governance Principles and Recommendations”.
StemSmart™: Advancing Stem Cell Therapy
A patented, high-quality platform for immune disease treatment
StemSmart™ is a globally patented technology designed to enhance the safety and efficacy of mesenchymal stem cell (MSC) therapies. Manufactured under GMP standards with a TGA product manufacturing licence, StemSmart™ products are consistently produced using a proprietary process that primes cells for stronger responses to inflammation. Early Phase 2 trial results in refractory Crohn’s disease indicate StemSmart™ MSC is potent, efficacious, and safe.